[1]
|
Pickup, J.C., Chusney, G.D., Thomas, S.M. and Burt, D. (2000) Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Science, 67, 291-300.
doi:10.1016/S0024-3205(00)00622-6
|
[2]
|
Mishima, Y., Kuyama, A., Tada, A., Takahashi, K., Ishioka, T. and Kibata, M. (2001) Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 52, 119-123.
doi:10.1016/S0168-8227(00)00247-3
|
[3]
|
Mavridis, G., Souliou, E., Diza, E., Symeonidis, G., Pastore, F., Vassiliou, A.M. and Karamitsos, D. (2008) Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Nutrition, Metabolism & Cardiovascular Diseases, 18, 471-476.
doi:10.1016/j.numecd.2007.02.013
|
[4]
|
Izzo, A.A., Borrelli, F., Capasso, R., Di Matzo, V. and Mechoulam, R., (2009) Non-psychotropic plant cannabinpids: New therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences, 30, 515-527.
doi:10.1016/j.tips.2009.07.006
|
[5]
|
Ben Amar, M. (2006) Cannabinoids in medicine: A review of their therapeutic potential. Journal of Ethnopharmacology, 105, 1-25.
doi:10.1016/j.jep.2006.02.001
|
[6]
|
Mechoulam, R., Peters, M., Murillo-Rodriguez, E. and Hanus, L.O. (2007) Cannabidiol—Recent advances. Chemistry & Biodiversity, 4, 1678-1692.
doi:10.1002/cbdv.200790147
|
[7]
|
Klein, T.W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L. and Friedman, H. (2003) The Cannabinoid system and immune modulation. Journal of Leukocyte Biology, 74, 486-496. doi:10.1189/jlb.0303101
|
[8]
|
Zurier, R.B. (2003) Prospects for Cannabinoids as anti-inflammatory agents. Journal of Cellular Biochemistry, 88, 462-466. doi:10.1002/jcb.10291
|
[9]
|
Mbvundula, E.C., Rainsford, K.D. and Bunning, R.A. (2004) Cannabinoids in pain and inflammation. Inflammopharmacology, 12, 99-114.
doi:10.1163/1568560041352275
|
[10]
|
Watzl, B., Scuderi, P. and Watson, R.R. (1991) Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro. Advances in Experimental Medicine and Biology, 288, 63-70.
|
[11]
|
Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S. and Gallily, R. (2006) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity, 39, 143-151.
doi:10.1080/08916930500356674
|
[12]
|
Weiss, L., Zeira, M., Reich, S., Slavin, S., Raz, I., Mechoulam, R., Gallily, R. (2008) Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology, 54, 244-249. doi:10.1016/j.neuropharm.2007.06.029
|
[13]
|
Malfait, A.M., Gallily, R., Sumariwalla, P.F., Malik, A.S., Andreakos, E., Mechoulam, R. and Feldmann, M. (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences of the United States of America, 97, 9561-9566.
doi:10.1073/pnas.160105897
|
[14]
|
Ziv, E., Kalman, R. and Shafrir, E. (2007) Psammomys obesus: Nutritionally induced insulin resistance, diabetes and beta cell loss. In: Shafrir, E., Ed., Animal Models of Diabetes, Second Edition, CRC Press, Boca Raton, 289-310.
|
[15]
|
Gaoni, Y. and Mechoulam, R. (1971) The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. Journal of the American Chemical Society, 93, 217-224.
doi:10.1021/ja00730a036
|
[16]
|
Shafrir, E., Ziv, E. and Kalman, R. (2006) Nutritionally induced diabetes in desert rodants as models of type 2 diabetes: Acomys Cahirinus (Spiny mice) and Psammomys obesus (desert gerbil). ILAR Journal, 47, 212-224.
|
[17]
|
Bar-On, H., Ben-Sasson, R., Ziv, E., Arar, N. and Shafrir, E. (1999) Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to β-cell apoptosis. Pancreas, 18, 259-265.
doi:10.1097/00006676-199904000-00007
|
[18]
|
Ziv, E., Kalman, R., Hershkop, K., Barash, V., Shafrir, E. and Bar-On, H. (1996) Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic-normoinsilinaemic state. Diabetologia, 39, 1269-1275.
doi:10.1007/s001250050569
|
[19]
|
Donath, M.Y., Gross, D.J., Cerasi, E. and Kaiser, N. (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes, 48, 738-744.
doi:10.2337/diabetes.48.4.738
|
[20]
|
Patane, G., Piro, S., Rabuazzo, A.M., Anello, M., Vigneri, R. and Purrello, F. (2000) Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: A direct metformin effect on pancreatic beta-cells. Diabetes, 49, 735-740.
doi:10.2337/diabetes.49.5.735
|
[21]
|
Pickup, J.C. (2004) Inflammation and activated innate immunity in the pathogenesis of type diabetes. Diabetes Care, 27, 813-823. doi:10.2337/diacare.27.3.813
|
[22]
|
Wellen, K.E. and Hotamisligil, G.S. (2005) Inflammation, stress and Diabetes. Journal of Clinical Investigation, 115, 1111-1119.
|
[23]
|
Marquie, G., Duhault, J., Espinal, J., Petkov, P., Jablenska, R., Khallayoun, S. and Bennani, N. (1997) S 15261, a novel agent for the treatment of insulin resistance. Studies on Psammomys obesus. Effect on pancreatic islets of insulin resistant animals. Cell and Molecular Biology (Noisy-le-grand), 43, 243-251.
|
[24]
|
Shafrir, E., Spielman, S., Nachliel, I., Khamaisi, M., Bar-On, H. and Ziv, E. (2001) Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil. Diabetes/Metabolism Research and Reviews, 17, 55-66.
doi:10.1002/1520-7560(2000)9999:9999<::AID-DMRR165>3.0.CO;2-J
|
[25]
|
Hefetz, S., Ziv, E., J?rns, A., Lenzen, S. and Shafrir, E. (2006) Prevention of nutritionally induced diabetes by rosiglitazone in the gerbil Psammomys obesus. Diabetes/ Metabolism Research and Reviews, 22,139-145.
doi:10.1002/dmrr.583
|
[26]
|
Sanigorski, A., Fahey, R., Cameron-Smith, D. and Collier, G.R. (2002) Nicotine treatment decreases food intake and body weight via a leptin-independent pathway in Psammomys obesus. Diabetes, Obesity and Metabolism, 4, 346-350. doi:10.1046/j.1463-1326.2002.00216.x
|
[27]
|
Anis, Y., Leshem, O., Reuveni, H., Wexler, I., Ben Sasson, R., Yahalom, B., Laster, M., Raz, I., Ben Sasson, S., Shafrir, E. and Ziv, E. (2004) Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia, 47, 1232-1244. doi:10.1007/s00125-004-1444-1
|
[28]
|
Shapira, M.Y., Appelbaum, Y.E., Hirshberg, B., Mizrahi, Y., Bar-On, H. and Ziv, E. (2000) A sustained, non-insulin related, hypoglycemic effect of electroacupuncture in diabetic Psammomys obesus. Diabetologia, 43, 809-813.
doi:10.1007/s001250051379
|
[29]
|
J?rns, A., Tiedge, M., Ziv, E., Shafrir, E. and Lenzen, S. (2002) Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat). Virchows Archiv, 440, 63-69. doi:10.1007/s004280100490
|
[30]
|
Like, A.A. and Miki, E. (1967) Diabetic syndrome in sand rats. IV. Morphologic changes in islet tissue. Diabetologia, 3, 143-166. doi:10.1007/BF01222192
|
[31]
|
Rajesh, M., Mukhopadhyay, P., Batkai, S., Hasko, G., Lioudet, L., Drel, V.R., Obrosova, I.G. and Pacher, P. (2007) Cannabidiol attenuates high glucose induced endothelial cell inflammatory response and barrier disruption. American Journal of Physiology—Heart and Circulatory Physiology, 293, H610-H619.
doi:10.1152/ajpheart.00236.2007
|
[32]
|
Kaiser, N., Yuli, M., Uckaya, G., Oprescu, A.I., Berthault, M.F., Kargar, C,, Donath, M.Y., Cerasi, E. and Ktorza, A. (2005) Dynamic changes in {beta}-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in Psammomys obesus: Impact of glycemic control. Diabetes, 54, 138-145.
doi:10.2337/diabetes.54.1.138
|
[33]
|
Leibowitz, G., Yuli, M., Donath, M.Y., Nesher, R., Melloul, D., Cerasi, E., Gross, D.J. and Kaiser, N. (2001) Beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes. Diabetes, 50, S113-S117.
doi:10.2337/diabetes.50.2007.S113
|
[34]
|
Plomgaard, P., Nielsen, A.R., Fischer, C.P., Mortensen, O.H., Broholm, C., Penkowa, M., Krogh-Madsen, R., Erikstrup, C., Lindegaard, B., Petersen, A.M., Taudorf, S. and Pedersen, B.K. (2007) Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia, 50, 2562-2571.
doi:10.1007/s00125-007-0834-6
|
[35]
|
Tsiotra, P.C., Tsigos, C., Yfanti, E., Anastasiou, E., Vikentiou, M., Psarra, K., Papasteriades, C. and Raptis, S.A. (2007) Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Hormone and Metabolic Research, 39, 758-763. doi:10.1055/s-2007-990288
|